ATE33556T1 - Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren. - Google Patents

Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.

Info

Publication number
ATE33556T1
ATE33556T1 AT83106808T AT83106808T ATE33556T1 AT E33556 T1 ATE33556 T1 AT E33556T1 AT 83106808 T AT83106808 T AT 83106808T AT 83106808 T AT83106808 T AT 83106808T AT E33556 T1 ATE33556 T1 AT E33556T1
Authority
AT
Austria
Prior art keywords
adenosine
cells
tumor cells
adp
atp
Prior art date
Application number
AT83106808T
Other languages
English (en)
Inventor
Eliezer Rapaport
Original Assignee
Eliezer Rapaport
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eliezer Rapaport filed Critical Eliezer Rapaport
Application granted granted Critical
Publication of ATE33556T1 publication Critical patent/ATE33556T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT83106808T 1982-07-13 1983-07-11 Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren. ATE33556T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/397,897 US4880918A (en) 1982-07-13 1982-07-13 Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
EP83106808A EP0100022B1 (de) 1982-07-13 1983-07-11 Adenosinderivate enthaltende pharmazeutische Zusammensetzung für Behandlung von Tumoren

Publications (1)

Publication Number Publication Date
ATE33556T1 true ATE33556T1 (de) 1988-05-15

Family

ID=23573118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83106808T ATE33556T1 (de) 1982-07-13 1983-07-11 Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.

Country Status (5)

Country Link
US (1) US4880918A (de)
EP (1) EP0100022B1 (de)
JP (1) JPS5921618A (de)
AT (1) ATE33556T1 (de)
DE (1) DE3376295D1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US7220854B1 (en) 1982-06-23 2007-05-22 Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides
US5227371A (en) * 1982-07-13 1993-07-13 Eliezer Rapaport Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations
US5049372A (en) * 1982-07-13 1991-09-17 Eliezer Rapaport Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
JPS5925325A (ja) * 1982-07-30 1984-02-09 Taiho Yakuhin Kogyo Kk 癌治療剤
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS6240252A (ja) * 1985-08-19 1987-02-21 Sakuma Kenji フライ食品の製造方法および装置
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US6180616B1 (en) 1990-05-10 2001-01-30 Atsuo F. Fukunaga Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US7671038B1 (en) * 1993-10-08 2010-03-02 Eliezer Rapaport Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
US6159701A (en) * 1996-11-08 2000-12-12 Link Technology Incorporated Method and compositions for treating and diagnosing tumors using adenosine receptor activated cells
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6680052B1 (en) 1999-11-08 2004-01-20 Endacea, Inc. Methods of inhibiting tumor growth using adenosine receptor activated cells
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
WO2003061568A2 (en) * 2002-01-16 2003-07-31 Eliezer Rapaport Methods and therapeutic compositions in the treatment of advanced cancer
US7148210B2 (en) * 2002-10-15 2006-12-12 Trustees Of Dartmouth College Method of treating bone metastasis
CA3010140C (en) 2015-12-29 2021-05-11 Marc Purcell Composition for energy supplementation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396609A (en) * 1975-02-18 1983-08-02 Sterling Drug Inc. Aminocyclitol antibiotics, pharmaceutical compositions and method of using same
JPS5634697A (en) * 1979-08-31 1981-04-06 Wakunaga Yakuhin Kk Preparation of 5'-triphosphoryladnylyl-(2'-5')-adenylyl-(2'-5')-adenosine

Also Published As

Publication number Publication date
EP0100022B1 (de) 1988-04-20
JPS5921618A (ja) 1984-02-03
US4880918A (en) 1989-11-14
DE3376295D1 (en) 1988-05-26
JPS637527B2 (de) 1988-02-17
EP0100022A1 (de) 1984-02-08

Similar Documents

Publication Publication Date Title
ATE33556T1 (de) Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.
ES2067508T3 (es) Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso.
ATE13487T1 (de) Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff.
SE8402550L (sv) N-substituerade deridvat av moranolin
DK471085D0 (da) Farmaceutiske sammensaetninger indeholdende syntetiske phospholipiderog et farmaceutisk aktivt stof samt deres fremstilling og anvendelse
MX168494B (es) Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas
DK474688A (da) Praeparat til bekaempelse af tumor eller kraeftceller
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
SE8303003D0 (sv) Medel for att oka antitumorverkan hos antitumormedel
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
ATE43967T1 (de) Antitumorale arzneimittel und verbindungen fuer behandlung von tumoren unter anwendung von (alpha, omega-bis(disubstituierte phosphino) kohlenwasserstoff> digold (i), digold (iii), disilber (i) und dikupfer (i)-derivaten.
Reuvers et al. Potential use of nitrofurans in radiotherapy
DE3484904D1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
SE8700555L (sv) Purinderivat, deras framstellning och lekemedel innehallande dessa
IE45054L (en) Veterinary composition
Campbell et al. Effect of environmental temperature on the metabolic response to injury
DE3781483D1 (de) Pharmazeutische zusammensetzung zum schutz von gehirnzellen.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
BIRKMAYER et al. Evidence for proflavine sensitive proteins in malignant hamster melanoma
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DK524185D0 (da) Pyrazindiazohydroxidforbindelser og fremgangsmaader til deres fremstilling og anvendelse
Montecuccoli et al. Inhibition by α-amanitin of chromosomal ribonucleic acid synthesis in rat liver

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee